Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $20 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on Core Scientific (NASDAQ:CORZ) and maintained a $20 price target.
September 03, 2024 | 4:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated its Overweight rating on Core Scientific, maintaining a $20 price target, indicating confidence in the company's future performance.
The reiteration of an Overweight rating and a $20 price target by a reputable analyst suggests a positive outlook for Core Scientific. This could lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100